Newgrange Blog
Does the UK Life Science and Technology Sector need the US?
An exclusive CXO Event hosted at the Royal Society of Medicine on Thursday 24th April 2025 by Frazier & Deeter, Newgrange Consultants and Compass Carter Osborne.
Filling life science product pipelines to boost grow
Big pharma companies have big cash reserves, so people often ask why they are not investing in investing when biotech is struggling for funds.
Why assess leaders and leadership teams?
Leadership talent is one of the most valuable assets of any organisation. Leadership talent is in high demand and short supply. Leadership impact is situational.